Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and telemetry and IT products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic doppler systems, central monitoring systems, video colposcopes, and biofeedback and stimulation systems. It also provides ultrasound systems that include cart-based color doppler, portable color doppler, and B/W ultrasound systems; and in-vitro diagnostics, which comprise hematology analyzers and reagents. In addition, the company offers point-of-care testing systems, including blood gas and chemistry analyzers, molecular diagnostic analysis systems, disposable arterial blood samplers, and blood gas capillary tubes; and veterinary ultrasound, ECG, laboratory, and monitoring products. The company was founded in 1995 and is headquartered in Shenzhen, China.
Chinese Market Performance
7D7 Days: 0.6%
3M3 Months: 9.9%
1Y1 Year: 34.3%
YTDYear to Date: 13.7%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. Meanwhile, the market is actually up 33% over the past year. Earnings are forecast to grow by 24% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.